| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/09/2009 | WO2009044213A1 Glycosylation markers for pancreatitis, sepsis and pancreatic cancer |
| 04/09/2009 | WO2009044170A1 Molecular adaptors |
| 04/09/2009 | WO2009044167A1 Assay device |
| 04/09/2009 | WO2009044153A2 Inhibitors and uses |
| 04/09/2009 | WO2009044119A1 Prognostic or diagnostic test |
| 04/09/2009 | WO2009044115A1 Endocrine disruptors |
| 04/09/2009 | WO2009044088A1 Assay device and method |
| 04/09/2009 | WO2009043986A1 Three-functional pseudo-peptidic reagent, and uses and applications thereof |
| 04/09/2009 | WO2009043962A1 Intracellular device which can be used as a biological activity sensor element or actuator |
| 04/09/2009 | WO2009043959A1 Method for identifying patients with sporadic burkitt's lymphoma, identification method and use of compounds for the treatment of sporadic burkitt's lymphoma |
| 04/09/2009 | WO2009043953A1 Use of truncated ppar-alpha inhibitors in the treatment of heart failure in patients with hypertensive cardiopathy |
| 04/09/2009 | WO2009043848A2 Use of the serological assay of the cytokine b-lymphocyte stimulator (blys) for the diagnosis, prognosis and the screening of therapeutic efficacy in immune-related diseases including organ-specific autoimmune diseases and transfusion reactions |
| 04/09/2009 | WO2009043829A1 Proteome-wide quantification of small molecule binding to cellular target proteins |
| 04/09/2009 | WO2009043795A1 Sampling device for buffered respiratory gas analysis |
| 04/09/2009 | WO2009043565A1 Method for identifying the interaction partner of an active agent |
| 04/09/2009 | WO2009043554A1 Method and measuring instrument for collecting spectrometric test signals from living tissue |
| 04/09/2009 | WO2009043393A1 Fertility test |
| 04/09/2009 | WO2009043173A1 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 04/09/2009 | WO2009043169A1 Granzyme a and granzyme b diagnostics |
| 04/09/2009 | WO2009043166A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/09/2009 | WO2009043159A1 Neural tumor stem cells and methods of use thereof |
| 04/09/2009 | WO2009043149A1 Analysis of conjugated metabolites of alcohol consumption |
| 04/09/2009 | WO2009043115A1 Method for identifying biomarkers which are diagnostic for a pathological condition |
| 04/09/2009 | WO2009043083A1 Method and composition for modulating androgen receptor activity |
| 04/09/2009 | WO2009021240A9 Sensing and identifying biological sampels on microfluidic devices |
| 04/09/2009 | WO2009019370A3 Apolipoprotein aii assay method for the in vitro diagnosis of colorectal cancer |
| 04/09/2009 | WO2009019369A3 I-plastin assay method for the in vitro diagnosis of colorectal cancer |
| 04/09/2009 | WO2009019365A3 Ezrin assay method for the in vitro diagnosis of colorectal cancer |
| 04/09/2009 | WO2009017861A3 Analyte detection using autocatalytic chain reactions |
| 04/09/2009 | WO2009009613A3 Novel ion channel-forming peptides |
| 04/09/2009 | WO2009007875A3 Photo acoustic sample detector with light guide |
| 04/09/2009 | WO2009006748A3 Method and system to detect neointima coverage of a stent |
| 04/09/2009 | WO2009006347A3 Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| 04/09/2009 | WO2009003441A3 Method for analysing the effect of a gaseous medium on a biological test system using an extracellular metabolisation system and device for carrying out said method |
| 04/09/2009 | WO2009001280A3 A method for the production of a microelectronic sensor device |
| 04/09/2009 | WO2008155778A4 Assay for detection of transient intracellular ca2+ |
| 04/09/2009 | WO2008155397A3 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases |
| 04/09/2009 | WO2008152239A3 Method of adjusting injection, combustion and/or post-treatment parameters of an internal combustion engine with auto-ignition |
| 04/09/2009 | WO2008152124A3 Biosensor |
| 04/09/2009 | WO2008150496A9 Assay for sensitivity to chemotherapeutic agents |
| 04/09/2009 | WO2008141285A3 Methods for early diagnosis of kidney disease |
| 04/09/2009 | WO2008140463A9 Biomarker panels for assessing radiation injury and exposure |
| 04/09/2009 | WO2008107724A3 Stabilisation of biological cell markers |
| 04/09/2009 | WO2008084402A3 Diagnosis and treatment of alzheimer's and other neurodementing diseases |
| 04/09/2009 | WO2008054773A3 Fertility enhancement using lipid carriers and bioactive molecules |
| 04/09/2009 | WO2008052185A3 Materials and methods for the treatment of celiac disease |
| 04/09/2009 | WO2008037720A3 Means and methods for diagnosing and/or treating a subject at risk of developing heart failure |
| 04/09/2009 | WO2008036697A9 Methods, systems and apparatus for light concentrating mechanisms |
| 04/09/2009 | WO2008030281A3 Optical resonances in droplets in a microchannel |
| 04/09/2009 | WO2008011624A3 Crystal structure of a receptor-ligand complex and methods of use |
| 04/09/2009 | WO2007133871A3 Two-phase optical assay with unitized container and double or single sensor systems |
| 04/09/2009 | WO2007123951A3 Methods and compositions for screening of glycan structures |
| 04/09/2009 | WO2007111875A3 Methods for diagnosing and treating kidney and colorectal cancer |
| 04/09/2009 | WO2007107996A3 Novel nucleotide and amino acid sequences and methods of use thereof for diagnosis |
| 04/09/2009 | WO2007098297A3 Method for diagnosing and treating kidney cancer |
| 04/09/2009 | WO2007096874A3 Blood oxygenation sensor |
| 04/09/2009 | WO2007078841A3 Diagnosis of sepsis |
| 04/09/2009 | WO2007076200A3 Antagonists of hmgb1 and/or rage and methods of use thereof |
| 04/09/2009 | WO2007070708A3 Immunodeficiency viruses |
| 04/09/2009 | WO2007067819A3 Optical molecular detection |
| 04/09/2009 | WO2007038414A3 Mining protein interaction networks |
| 04/09/2009 | WO2007005946A3 Detection of rho proteins |
| 04/09/2009 | WO2007005443A3 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors |
| 04/09/2009 | WO2006124714A3 Method for detecting atherosclerosis |
| 04/09/2009 | WO2006124408A3 System and method for automated selection of t-cell epitopes |
| 04/09/2009 | WO2006121510A3 Point-of-care fluidic systems and uses thereof |
| 04/09/2009 | WO2006105110A3 Assay device and methods |
| 04/09/2009 | WO2006104510A3 Water-soluble compound |
| 04/09/2009 | WO2006099248A3 Drug delivery from electroactive molecularly imprinted polymer |
| 04/09/2009 | WO2006094014A3 Methods for diagnosis and treatment of endometrial cancer |
| 04/09/2009 | WO2006091309A3 System and method for implementing a high-sensitivity sensor with improved stabdlity |
| 04/09/2009 | WO2006086566A3 Methods and apparatuses for noninvasive determinations of analytes |
| 04/09/2009 | WO2006084092A3 Antibodies to oncostatin m receptor |
| 04/09/2009 | WO2006079101A3 Associations using genotypes and phenotypes |
| 04/09/2009 | WO2006078814A3 Cellular microarrays for screening differentiation factors |
| 04/09/2009 | WO2006076024A3 A method for targeting synapse with acetylcholinesterase |
| 04/09/2009 | WO2006068917A3 Process of treating a cell |
| 04/09/2009 | WO2006063174A3 Compositions for binding to assay substrata and methods of using |
| 04/09/2009 | WO2006063135A3 Tubulin isotype screnning in cancer therapy using hemiasterlin analogs |
| 04/09/2009 | WO2006060291A3 Apparatus and method for transferring data to a pharmaceutical compounding system |
| 04/09/2009 | WO2006058277A3 Method for identifying and designing immunogenic peptides |
| 04/09/2009 | WO2006055680A3 Method for determining three-dimensional protein structure from primary protein sequence |
| 04/09/2009 | WO2006055665A3 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 04/09/2009 | WO2006047299A3 Organotypic slice cultures and uses thereof |
| 04/09/2009 | WO2006039630A3 Materials and methods for identifying compounds that modulate the cell cycle |
| 04/09/2009 | WO2006033768A3 Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof |
| 04/09/2009 | WO2006031524A3 Early detection of hemangiosarcoma and angiosarcoma |
| 04/09/2009 | WO2006029302A3 Dioxetane-nanoparticle assemblies for energy transfer detection systems, methods of making the assemblies, and methods of using the assemblies in bioassays |
| 04/09/2009 | WO2006020550A3 Analyte sensors and method for constructing analyte binding motifs |
| 04/09/2009 | WO2006007400A9 Methods of diagnosing and treating obesity, diabetes and insulin resistance |
| 04/09/2009 | WO2005123954A3 Methods for target molecule detection using siderophores and related compositions |
| 04/09/2009 | WO2005118876A3 Egfr mutations |
| 04/09/2009 | WO2005111073A3 Channel forming peptides |
| 04/09/2009 | WO2005086775A3 Lumen-exposed molecules and methods for targeted delivery |
| 04/09/2009 | WO2005081872A3 Methods and compositions comprising supramolecular constructs |
| 04/09/2009 | WO2005079548A3 Narcotic analgesic tracking system |
| 04/09/2009 | WO2005072507A3 Biomarker detection in circulating cells |
| 04/09/2009 | WO2005067649A3 Use of databases to create gene expression microarrays |
| 04/09/2009 | WO2005047305A3 Cellular membrane protein assay |
| 04/09/2009 | WO2005041684A3 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |